Varelas to distribute VarSome Clinical in Greece

Posted by Tomas Kucera on Oct 3, 2019 4:28:35 PM

Lausanne, Switzerland - October 3, 2019 - Saphetor SA, a Swiss precision-medicine company and leader in diagnostic and bioinformatics solutions for clinical Next Generation Sequencing (NGS), announced today a distribution agreement with Varelas, a distributor for clinical applications in Greece. Saphetor’s VarSome Clinical, a clinically-certified platform for interpretation of NGS data extends Varelas’s portfolio of tools and services for a wide range of its clients employing NGS technologies for clinical as well as for research purposes.

Immuno Diagnostic Oy to distribute VarSome Clinical in Finland

Posted by Tomas Kucera on Sep 18, 2019 7:17:52 AM

Lausanne, Switzerland - September 18, 2019 - Saphetor SA, a Swiss precision-medicine company and leader in diagnostic and bioinformatics solutions for clinical Next Generation Sequencing (NGS), announced today a distribution agreement with Immuno Diagnostic Oy, an authorized distributor in Finland for clinical applications in Finland. Saphetor’s VarSome Clinical, a clinically-certified platform for interpretation of NGS data extends Immuno Diagnostic’s portfolio of tools and services for a wide range of its clients employing NGS technologies for clinical as well as for research purposes.

Perlan Technologies to distribute VarSome Clinical in Poland

Posted by Tomas Kucera on Jul 18, 2019 1:58:41 PM

Lausanne, Switzerland - July 18, 2019 - Saphetor SA, a Swiss precision-medicine company and leader in diagnostic and bioinformatics solutions for clinical Next Generation Sequencing (NGS), announced today a distribution agreement with Perlan Technologies Polska sp. z o.o., an authorized distributor of Agilent Technologies for Poland. Saphetor’s VarSome Clinical, a clinically-certified platform for interpretation of NGS data extends Perlan’s portfolio of tools and services for a wide range of its clients employing NGS technologies for clinical as well as for research purposes.

VarSome and Swift Biosciences announce partnership to standardize and accelerate data interpretation for targeted NGS panels

Posted by Tomas Kucera on Jun 12, 2019 11:45:01 PM

Lausanne, June 12th, 2019. Saphetor SA, a Swiss precision medicine company and the creator of VarSome, a suite of bioinformatics solutions, announced today a partnership with Swift Biosciences Inc., a Michigan company based in Ann Arbor, USA, offering a set of differentiated next-generation sequencing (NGS) products and technologies for genomics, translational, and clinical research applications.

Molecular Vision Laboratory implements VarSome Clinical in its diagnostic workflow

Posted by Tomas Kucera on May 21, 2019 4:28:06 PM

Lausanne, May 21th, 2019. Saphetor SA, a Swiss precision medicine company and the creator of VarSome, a suite of advanced bioinformatics solutions, announced today a partnership with Molecular Vision Laboratory (MVL), a CAP and CLIA-certified medical diagnostic laboratory based in Oregon, USA, providing comprehensive genetic NGS-based testing for inherited retinal dystrophies.

PMKB now available on VarSome!

Posted by Tomas Kucera on Jan 10, 2019 2:22:41 PM

New York and Lausanne, Switzerland - January 10, 2019 - Saphetor SA, the creator of VarSome, announced today a partnership with the Englander Institute for Precision Medicine at Weill Cornell Medicine, the creator of Precision Medicine Knowledgebase (PMKB), a curated resource for the clinical interpretation of cancer variants [1]. PMKB is now a fundamental component of VarSome’s portfolio of over 30 integrated and cross-referenced public data resources as well as VarSome’s implementation of the American College of Medical Genetics guidelines.